INTRODUCTION: The kinesin family number 3A (KIF3A) gene on the human chromosomal 5q31-33 region, which is known as a susceptibility locus for immune diseases including asthma, plays a crucial role in generation of cilia. RESULTS: A treatment with aspirin in the human bronchial epithelial cells increased the mRNA expression level of KIF3A compared to that of the untreated control (P ≤ 0.01), and nasal polyp epithelia from aspirin-intolerant asthma (AIA) patients also showed a higher expression of KIF3A protein than aspirin-tolerant asthma controls. Further logistic analyses revealed that most polymorphisms of KIF3A were significantly associated with AIA (P = 0.0004-0.02; P(corr) = 0.004-0.04) and the decline of forced expiratory volume at 1 s (FEV(1))% by aspirin provocation (P = 0.004-0.04; P(corr) = 0.03). DISCUSSION: Our findings suggest that the KIF3A gene and/or its polymorphisms might have a susceptibility effect on AIA, providing a new step toward controlling aspirin intolerance in asthmatics.
INTRODUCTION: The kinesin family number 3A (KIF3A) gene on the human chromosomal 5q31-33 region, which is known as a susceptibility locus for immune diseases including asthma, plays a crucial role in generation of cilia. RESULTS: A treatment with aspirin in the human bronchial epithelial cells increased the mRNA expression level of KIF3A compared to that of the untreated control (P ≤ 0.01), and nasal polyp epithelia from aspirin-intolerant asthma (AIA) patients also showed a higher expression of KIF3A protein than aspirin-tolerant asthma controls. Further logistic analyses revealed that most polymorphisms of KIF3A were significantly associated with AIA (P = 0.0004-0.02; P(corr) = 0.004-0.04) and the decline of forced expiratory volume at 1 s (FEV(1))% by aspirin provocation (P = 0.004-0.04; P(corr) = 0.03). DISCUSSION: Our findings suggest that the KIF3A gene and/or its polymorphisms might have a susceptibility effect on AIA, providing a new step toward controlling aspirin intolerance in asthmatics.
Authors: N Shimokawa; C Nishiyama; T Hirota; M Tamari; M Hara; S Ikeda; K Okumura; H Ogawa Journal: Clin Exp Allergy Date: 2008-12-23 Impact factor: 5.018
Authors: P Kauppi; K Lindblad-Toh; P Sevon; H T Toivonen; J D Rioux; A Villapakkam; L A Laitinen; T J Hudson; J Kere; T Laitinen Journal: Genomics Date: 2001-09 Impact factor: 5.736
Authors: Elisabet Johansson; Jocelyn M Biagini Myers; Lisa J Martin; Hua He; Patrick Ryan; Grace K LeMasters; David I Bernstein; James Lockey; Gurjit K Khurana Hershey Journal: Clin Exp Allergy Date: 2019-03-27 Impact factor: 5.018
Authors: Premkumar Vummidi Giridhar; Sheila M Bell; Anusha Sridharan; Priya Rajavelu; Joseph A Kitzmiller; Cheng-Lun Na; Matthew Kofron; Eric B Brandt; Mark Ericksen; Anjaparavanda P Naren; Changsuk Moon; Gurjit K Khurana Hershey; Jeffrey A Whitsett Journal: J Immunol Date: 2016-10-28 Impact factor: 5.422
Authors: E Kaitlynn Allen; Wei-Min Chen; Daniel E Weeks; Fang Chen; Xuanlin Hou; José L Mattos; Josyf C Mychaleckyj; Fernando Segade; Margaretha L Casselbrant; Ellen M Mandel; Robert E Ferrell; Stephen S Rich; Kathleen A Daly; Michèle M Sale Journal: J Assoc Res Otolaryngol Date: 2013-08-23
Authors: Melinda Butsch Kovacic; Jocelyn M Biagini Myers; Ning Wang; Lisa J Martin; Mark Lindsey; Mark B Ericksen; Hua He; Tia L Patterson; Tesfaye M Baye; Dara Torgerson; Lindsey A Roth; Jayanta Gupta; Umasundari Sivaprasad; Aaron M Gibson; Anna M Tsoras; Donglei Hu; Celeste Eng; Rocío Chapela; José R Rodríguez-Santana; William Rodríguez-Cintrón; Pedro C Avila; Kenneth Beckman; Max A Seibold; Chris Gignoux; Salma M Musaad; Weiguo Chen; Esteban González Burchard; Gurjit K Khurana Hershey Journal: PLoS One Date: 2011-08-30 Impact factor: 3.240